English  |  正體中文  |  简体中文  |  2826208  
???header.visitor??? :  31905034    ???header.onlineuser??? :  1553
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"shih j y"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 876-900 of 1137  (46 Page(s) Totally)
<< < 31 32 33 34 35 36 37 38 39 40 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-03-07T06:56:39Z Comparison of p53 and epidermal growth factor receptor gene status between primary tumors and lymph node metastases in non-small cell lung cancers YIH-LEONG CHANG; Yih-Leong Chang ;Wu C.-T. ;Shih J.-Y. ;Lee Y.-C.; Lee Y.-C.; Shih J.-Y.; Wu C.-T.
臺大學術典藏 2020-03-07T06:56:39Z Unique p53 and epidermal growth factor receptor gene mutation status in 46 pulmonary lymphoepithelioma-like carcinomas Yih-Leong Chang ;Wu C.-T. ;Shih J.-Y. ;Lee Y.-C.; YIH-LEONG CHANG; Wu C.-T.; Shih J.-Y.; Lee Y.-C.
臺大學術典藏 2020-03-07T06:56:39Z Epidermal growth factor receptor mutations in small cell lung cancer: A brief report Shiao T.-H. ;Yih-Leong Chang ;Yu C.-J. ;Chang Y.-C. ;Hsu Y.-C. ;Chang S.-H. ;Shih J.-Y. ;Yang P.-C.; Shiao T.-H.; YIH-LEONG CHANG; Yu C.-J.; Chang Y.-C.; Hsu Y.-C.; Chang S.-H.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2020-03-07T06:56:38Z Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations Wu S.-G. ;Yang C.-H. ;Yu C.-J. ;Lee J.-H. ;Hsu Y.-C. ;Yih-Leong Chang ;Shih J.-Y. ;Yang P.-C.; Wu S.-G.; Yang C.-H.; Yu C.-J.; Lee J.-H.; Hsu Y.-C.; YIH-LEONG CHANG; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2020-03-07T06:56:38Z Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction Wu S.-G. ;Yih-Leong Chang ;Lin J.-W. ;Wu C.-T. ;Chen H.-Y. ;Tsai M.-F. ;Lee Y.-C. ;Yu C.-J. ;Shih J.-Y.; Wu S.-G.; YIH-LEONG CHANG; Lin J.-W.; Wu C.-T.; Chen H.-Y.; Tsai M.-F.; Lee Y.-C.; Yu C.-J.; Shih J.-Y.
臺大學術典藏 2020-03-07T06:56:38Z Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations Wu J.-Y. ;Wu S.-G. ;Yang C.-H. ;Yih-Leong Chang ;Chang Y.-C. ;Hsu Y.-C. ;Shih J.-Y. ;Yang P.-C.; Wu J.-Y.; Wu S.-G.; Yang C.-H.; YIH-LEONG CHANG; Chang Y.-C.; Hsu Y.-C.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2020-03-07T06:56:37Z Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed Chen C.-Y. ;Yih-Leong Chang ;Shih J.-Y. ;Lin J.-W. ;Chen K.-Y. ;Yang C.-H. ;Yu C.-J. ;Yang P.-C.; Chen C.-Y.; YIH-LEONG CHANG; Shih J.-Y.; Lin J.-W.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2020-03-07T06:56:37Z Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations Yuan S.; Yu S.-L.; Chen H.-Y.; Hsu Y.-C.; Su K.-Y.; Chen H.-W.; Chen C.-Y.; Yu C.-J.; Shih J.-Y.; YIH-LEONG CHANG; Cheng C.-L.; Hsu C.-P.; Hsia J.-Y.; Lin C.-Y.; Wu G.; Liu C.-H.; Wang C.-D.; Yang K.-C.; Chen Y.-W.; Lai Y.-L.; Hsu C.-C.; Lin T.-C.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Chen J.J.W.; Chang G.-C.; Li K.-C.; Yang P.-C.; Yuan S. ;Yu S.-L. ;Chen H.-Y. ;Hsu Y.-C. ;Su K.-Y. ;Chen H.-W. ;Chen C.-Y. ;Yu C.-J. ;Shih J.-Y. ;Yih-Leong Chang ;Cheng C.-L. ;Hsu C.-P. ;Hsia J.-Y. ;Lin C.-Y. ;Wu G. ;Liu C.-H. ;Wang C.-D. ;Yang K.-C. ;Chen Y.-W. ;Lai Y.-L. ;Hsu C.-C. ;Lin T.-C. ;Yang T.-Y. ;Chen K.-C. ;Hsu K.-H. ;Chen J.J.W. ;Chang G.-C. ;Li K.-C. ;Yang P.-C.
臺大學術典藏 2020-03-07T06:56:35Z Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment Chung K.-P.; Huang Y.-T.; YIH-LEONG CHANG; Yu C.-J.; Yang C.-H.; Chang Y.-C.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2020-03-07T06:56:35Z EGFR and p53 status of pulmonary pleomorphic carcinoma: Implications for EGFR tyrosine kinase inhibitors therapy of an aggressive lung malignancy Yih-Leong Chang ;Wu C.-T. ;Shih J.-Y. ;Lee Y.-C.; YIH-LEONG CHANG; Wu C.-T.; Shih J.-Y.; Lee Y.-C.
臺大學術典藏 2020-03-07T06:56:35Z EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR Wu S.-G.;Kuo Y.-W.;Yih-Leong Chang;Shih J.-Y.;Chen Y.-H.;Tsai M.-F.;Yu C.-J.;Yang C.-H.;Yang P.-C.; Wu S.-G.; Kuo Y.-W.; YIH-LEONG CHANG; Shih J.-Y.; Chen Y.-H.; Tsai M.-F.; Yu C.-J.; Yang C.-H.; Yang P.-C.
臺大學術典藏 2020-03-07T06:56:35Z Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma Tsai T.-H.; Wu S.-G.; YIH-LEONG CHANG; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2020-03-07T06:56:34Z RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer Tsai T.-H.; Su K.-Y.; Wu S.-G.; YIH-LEONG CHANG; Luo S.-C.; Jane I.-S.; Yu C.-J.; Yue S.-L.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2020-03-07T06:56:33Z The significance of visceral pleural surface invasion in 321 cases of non-small cell lung cancers with pleural retraction YIH-LEONG CHANG; Lin M.-W.; Shih J.-Y.; Wu C.-T.; Lee Y.-C.
臺大學術典藏 2020-03-07T06:56:33Z Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis Wu S.-G.; Hu F.-C.; YIH-LEONG CHANG; Lee Y.-C.; Yu C.-J.; Chang Y.-C.; Wu J.-Y.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2020-03-07T06:56:27Z Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ≤2 cm in maximal dimension Lin M.-W.; Wu C.-T.; Shih J.-Y.; YIH-LEONG CHANG; Yang P.-C.
臺大學術典藏 2020-03-07T06:56:27Z Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations Chen Y.-F.;Hsieh M.-S.;Wu S.-G.;Yih-Leong Chang;Shih J.-Y.;Liu Y.-N.;Tsai M.-F.;Tsai T.-H.;Yu C.-J.;Yang J.C.-H.;Yang P.-C.; YIH-LEONG CHANG; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; Chen Y.-F.; Hsieh M.-S.; Wu S.-G.
臺大學術典藏 2020-03-07T06:56:26Z Multidriver mutation analysis in pulmonary mucinous adenocarcinoma in Taiwan: Identification of a rare CD74-NRG1 translocation case Gow C.-H.; Wu S.-G.; YIH-LEONG CHANG; Shih J.-Y.
臺大學術典藏 2020-03-07T06:56:23Z DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers Lin Y.-C.;Lin Y.-C.;Shih J.-Y.;Huang W.-J.;Chao S.-W.;Yih-Leong Chang;Chen C.-C.; Lin Y.-C.; Lin Y.-C.; Shih J.-Y.; Huang W.-J.; Chao S.-W.; YIH-LEONG CHANG; Chen C.-C.
臺大學術典藏 2020-03-07T06:56:19Z Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations Chen Y.-F.;Hsieh M.-S.;Wu S.-G.;Yih-Leong Chang;Yu C.-J.;Yang J.C.-H.;Yang P.-C.;Shih J.-Y.; Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; YIH-LEONG CHANG; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2020-03-07T06:56:18Z The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients Wu S-G.; Liu Y.-N.; Tsai M.-F.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C.; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y.
臺大學術典藏 2020-03-07T06:56:16Z The role of PIK3CA mutations among lung adenocarcinoma patients with primary and acquired resistance to EGFR tyrosine kinase inhibition Wu S.-G.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2020-03-07T06:56:13Z Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expression Chen C.-Y.;Chen Y.-Y.;Chen J.J.W.;Chen K.-Y.;Ho C.-C.;Shih J.-Y.;Yih-Leong Chang;Yu C.-J.;Yang P.-C.; Chen C.-Y.; Chen Y.-Y.; Chen J.J.W.; Chen K.-Y.; Ho C.-C.; Shih J.-Y.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C.
臺大學術典藏 2020-03-07T06:56:13Z Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C Chen Y.-W.; Kuo P.-Y.; Yang P.-C.; Shih J.-Y.; Chang T.-H.;Tsai M.-F.;Gow C.-H.;Wu S.-G.;Liu Y.-N.;Yih-Leong Chang;Yu S.-L.;Tsai H.-C.;Lin S.-W.;Chen Y.-W.;Kuo P.-Y.;Yang P.-C.;Shih J.-Y.; Chang T.-H.; Tsai M.-F.; Gow C.-H.; Wu S.-G.; Liu Y.-N.; YIH-LEONG CHANG; Yu S.-L.; Tsai H.-C.; Lin S.-W.
臺大學術典藏 2020-03-07T06:56:12Z Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; YIH-LEONG CHANG; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.; Lin C.-C.;Shih J.-Y.;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tsai T.-H.;Su K.-Y.;Hsieh M.-S.;Yih-Leong Chang;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.

Showing items 876-900 of 1137  (46 Page(s) Totally)
<< < 31 32 33 34 35 36 37 38 39 40 > >>
View [10|25|50] records per page